Growth Metrics

Cytosorbents (CTSO) Share-based Compensation Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 9.69%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 3.57%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -4.08%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 12.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 12.94%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 26.61%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 59.09%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 31.63%
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn -33.50%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -33.50%
Dec 31, 2025 -3.70%
Sep 30, 2025 -45.23%
Jun 30, 2025 -42.26%
Mar 31, 2025 -14.74%
Dec 31, 2024 -44.86%
Sep 30, 2024 -17.96%
Jun 30, 2024 73.51%
Mar 31, 2024 15.60%
Dec 31, 2023 91.87%
Sep 30, 2023 8.06%
Jun 30, 2023 -25.10%
Mar 31, 2023 5.41%
Dec 31, 2022 9.13%
Sep 30, 2022 0.60%
Jun 30, 2022 -51.16%
Mar 31, 2022 -49.46%
Dec 31, 2021 -68.37%
Sep 30, 2021 -8.18%
Jun 30, 2021 48.95%
Mar 31, 2021 113.59%
Dec 31, 2020 413.01%
Sep 30, 2020 35.66%
Jun 30, 2020 621.38%
Mar 31, 2020 220.41%
Dec 31, 2019 -68.79%
Sep 30, 2019 192.70%
Jun 30, 2019 -92.98%
Mar 31, 2019 4.81%
Dec 31, 2018 7.56%
Sep 30, 2018 -71.46%
Jun 30, 2018 158.67%
Mar 31, 2018 135.39%
Dec 31, 2017 599.87%
Sep 30, 2017 672.61%
Jun 30, 2017 62.11%
Mar 31, 2017 -13.82%
Dec 31, 2016 -339.79%
Sep 30, 2016 9.19%
Jun 30, 2016 494.69%
Mar 31, 2016 68.42%
Sep 30, 2015 51.25%
Jun 30, 2015 74.47%
Mar 31, 2015 10.82%
Sep 30, 2014 137.43%
Jun 30, 2014 16.99%
Mar 31, 2014 -74.60%
Dec 31, 2013 748.00%
Sep 30, 2013 -1,716.97%
Jun 30, 2013 914.75%
Mar 31, 2013 42,362.41%
Dec 31, 2012 -87.09%
Sep 30, 2012 -96.23%
Jun 30, 2012 104.50%
Mar 31, 2012 -99.70%
Dec 31, 2011 777.63%
Sep 30, 2011 1,554.22%